MergerLinks Daily Review
MergerLinks
Join a community of 250,000+ M&A professionals. Expand your network and discover new business opportunities.
Welcome to MergerLinks Daily Review.?Sign up here?to get the full round up of your daily dose of blue-chip M&A news directly to your inbox.
UK delivers final blow to UAE's hopes of acquiring Telegraph newspaper.
You can access today’s complete newsletter?here.
Scroll down for more…
思科 , a multinational digital communications technology conglomerate corporation, completed the acquisition of Splunk , a machine-generated data analytic software company, for $30bn.
"We are thrilled to officially welcome Splunk to Cisco. As one of the world's largest software companies, we will revolutionize the way our customers leverage data to connect and protect every aspect of their organization as we help power and protect the AI revolution," Chuck Robbins , Cisco Chair and CEO.
Splunk was advised by 摩根士丹利 (led by David Chen and Anthony Armstrong ), Qatalyst Partners (led by George Boutros ), Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates (led by Mike Ringler and Peter Jones ), and Joele Frank (led by Eric Brielmann ). Financial advisors were advised by Cooley LLP (led by Jamie Leigh ) and 富而德律师事务所 . Cisco was advised by 花旗 , The Consello Group , 高盛 (led by Ryan Limaye ), J.P. 摩根 , RBC Capital Markets , Tidal Partners (led by David Handler ), Clifford Chance (led by Nelson Jung ), Cravath, Swaine & Moore LLP and Simpson Thacher & Bartlett LLP (led by Alan M. Klein , Anthony Vernace and Fred de Albuquerque ). Financial advisors to Cisco was advised by Latham & Watkins (led by Justin G. Hamill ).
Clearlake Capital Group , a private equity firm, and Insight Partners, a venture capital and private equity firm, completed the acquisition of Alteryx , a computer software company, for $4.4bn.
"We believe the Alteryx AI and cloud analytics platform provides powerful and differentiated solutions that enable customers to gain critical insights from data driven workflows, ultimately leading to meaningful productivity and efficiency gains for these organizations. In partnership with Insight, we are excited to collaborate with the company's talented employee base and believe that through Clearlake's O.P.S.? framework and sector expertise, Alteryx will have the resources to accelerate its product innovation and continue to provide valuable solutions to customers," Behdad Eghbali , Clearlake Co-Founder and Managing Partner and Prashant Mehrotra , Clearlake Partner and Managing Director.
Alteryx was advised by Qatalyst Partners (led by George Boutros and Jeff Chang ), Fenwick & West (led by Michael Pilo , Michael Brown , Ran Ben-Tzur , and David Michaels ), Wilson Sonsini Goodrich & Rosati (led by Martin Korman, Raj Judge , Jack Hamilton , Douglas Schnell , and Remi Korenblit ) and Joele Frank (led by Barrett Golden and Eric Brielmann ). Insight Partners was advised by Willkie Farr & Gallagher LLP (led by Erin Kinney and Matthew Guercio ). Clearlake Capital was advised by 高盛 (led by Ryan Limaye ), Houlihan Lokey , J.P. 摩根 , 摩根士丹利 , Sidley Austin LLP (led by Mehdi Khodadad , Mark Castiglia , and Daniel Belke ) and Lambert (led by Jennifer Hurson ). Debt financing was provided by Apollo Global Management, Inc. , Blackstone , Blue Owl Capital and Sixth Street .
领英推荐
阿斯利康 , a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines, agreed to acquire Fusion Pharmaceuticals , a clinical-stage oncology company, for $2bn.
"This acquisition combines Fusion's expertise and capabilities in radioconjugates, including our industry-leading radiopharmaceutical R&D, pipeline, manufacturing and actinium-225 supply chain, with AstraZeneca's leadership in small molecules and biologics engineering to develop novel radioconjugates. Expanding on our existing collaboration with AstraZeneca where we have advanced FPI-2068, an EGFR-cMET targeted radioconjugate into Phase I clinical trials, gives us a unique opportunity to accelerate the development of next-generation radioconjugates with the aim of transforming patient outcomes," John Valliant , Fusion CEO.
?
Fusion Pharmaceuticals is advised by Centerview Partners , Goodwin , and Osler, Hoskin & Harcourt LLP .
Australia's Boral on March 19 recommended investors reject its largest shareholder SGH Ltd ' AUD1.9bn ($1.25bn) offer for the company claiming it undervalues the building products group, Reuters reported.
Seven Group, controlled by billionaire Kerry Stokes and his family, already owns nearly 72% of Boral and had launched a bid last month to acquire full control of Boral.
The proposal of a minimum of SUD6.05 per Boral share consists of 0.1116 Seven Group shares and AUD1.50 cash. The offer could go as high as AUD6.39 per share if certain acceptance rates are met.
Boral is advised by 瑞银集团 , Allens and FTI Consulting (led by Shane Murphy ). Seven Group is advised by Domestique (led by Jim Kelly ).
UK delivers final blow to UAE's hopes of acquiring Telegraph newspaper.
Britain said on March 19 it would refer the UAE-led takeover of the The Telegraph for a lengthy review, a move that will effectively kill the deal because a law banning foreign governments owning newspapers is due to come into force in coming months, Reuters reported.
Abu Dhabi-backed RedBird IMI took control of the Telegraph titles and the Spectator magazine in December when it helped repay the Barclay family's ￡1.2bn ($1.5bn) debt to Lloyds Bank , but the deal needs regulatory approval.
Interested to find more??Sign up here?to get full round up of your daily dose of blue-chip M&A news directly to your inbox.
You can access today’s complete newsletter?here.